Redmile Group, LLC

SEC CIK: 0001425738
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

APRE holding history

Aprea Therapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APRE overview All 13F holders of APRE Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of APRE by Redmile Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−694,918−100.0%	Sold out	Holders
Q3 2021	694,918	$3.55M	0.1%	00.0%	Unchanged	Holders
Q2 2021	694,918	$3.39M	0.1%	00.0%	Unchanged	Holders
Q1 2021	694,918	$3.54M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.